Average Co-Inventor Count = 3.33
ph-index = 5
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Gigagen, Inc. (21 from 21 patents)
2. Gigamune, Inc. (5 from 5 patents)
3. Natera, Inc. (2 from 108 patents)
28 patents:
1. 12497711 - Engineered Cells Expressing Anti-Viral T Cell Receptors and Methods of Use Thereof
2. 12421311 - Anti-CTLA-4 binding proteins and methods of use thereof
3. 12404607 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof
4. 12371689 - Engineered enveloped vectors and methods of use thereof
5. 12241178 - Recombinant fusion proteins and libraries from immune cell repertoires
6. 12195880 - Systems and methods for massively parallel combinatorial analysis of single cells
7. 11718660 - Recombinant polyclonal proteins targeting Zika and methods of use thereof
8. 11702765 - Recombinant fusion proteins and libraries from immune cell repertoires
9. 11685779 - Recombinant polyclonal proteins targeting COVID-19 and methods of use thereof
10. 11591652 - System and methods for massively parallel analysis of nucleic acids in single cells
11. 11441240 - Systems and methods for massively parallel combinatorial analysis of single cells
12. 11427933 - Systems and methods for massively parallel combinatorial analysis of single cells
13. 11421220 - Engineered cells expressing anti-viral T cell receptors and methods of use thereof
14. 11111490 - Systems and methods for massively parallel combinatorial analysis of single cells
15. 11053543 - System and methods for massively parallel analysis of nucleic acids in single cells